جست‌وجوی استاد و پژوهشگر

• Innate Immunity
• Inflammasome Biology
• Nucleic-Acid Sensing
• +۶ مورد دیگر

Katherine A. Fitzgerald, PhD , is Professor and Vice Chair of Medicine at the University of Massachusetts Chan Medical School , where she also serves as Chief of the Division of Innate Immunity and holds the Worcester Foundation for Biomedical Research Chair III . She is cross-appointed in multiple graduate programs at the Morningside Graduate School of Biomedical Sciences , including Immunology and Microbiology, Translational Science, MD/PhD, and Post-baccalaureate Research Education. Education B.Sc. in Biochemistry, University College Cork, Ireland (1995) Ph.D. in Biochemistry, Trinity College Dublin, Ireland (1999) Research Focus Dr. Fitzgerald’s work is centered on the molecular basis of innate immunity , dissecting how nucleic-acid sensors, inflammasomes, and long non-coding RNAs orchestrate inflammatory responses during infection and in chronic inflammatory diseases. Her laboratory aims to translate these insights into therapeutic strategies for infectious, autoimmune, and autoinflammatory disorders. Scientific Honors Member, National Academy of Sciences (USA) Member, National Academy of Medicine (USA) Member, Royal Irish Academy Fellow, American Academy of Microbiology Thermo-Fisher Meritorious Career Award (2022) Saint Patrick’s Day Medal (2015) Milstein Award for Excellence in Interferon and Cytokine Research (2014) Leadership & Service Past President of the International Cytokine and Interferon Society, she serves on national advisory boards including NIAID’s Board of Scientific Councillors and the Massachusetts Center for Pathogen Readiness. Laboratory & Training Her Fitzgerald Lab (Program in Innate Immunity) welcomes graduate rotation students; interested applicants should contact Kate.Fitzgerald@umassmed.edu .

• Network Biology
• Computational Systems Medicine
• Proteomics
• +۴ مورد دیگر

Jörg Menche holds a full Professor position (Univ.-Prof.) at the University of Vienna, with dual appointments in the Faculty of Mathematics, Department of Mathematics, and Max Perutz Labs, Department of Structural and Computational Biology. His work bridges mathematical modeling and biomedical research through network-based approaches to complex disease mechanisms. Primary research interests include Network Biology, Computational Systems Medicine, and Immunometabolism, with specific focus on proteomic signatures in neuropathic pain, metabolic reprogramming in obesity, and autoimmunity networks. He develops innovative computational tools like VRNetzer for virtual reality network analysis and BioProfiling.jl for high-content imaging data integration, targeting intersections between metabolism, immunity, and environmental exposures. Recent publications (2019-2024) reveal a dominant trend in multi-omics network medicine, particularly in autoimmunity (AutoCore framework), cardiometabolic diseases, and rare genetic disorders. His work demonstrates exceptional translational impact, with multiple papers highlighted by news outlets and patents (e.g., 3 patents referencing 2021 research). While the text indicates involvement in one project (2016) and 13 activities, grant specifics and student mentoring details remain undisclosed. His collaborative network spans immunology, neuroscience, and toxicology, evidenced by co-authorships with clinical and computational teams. Menche operates within Max Perutz Labs, a premier molecular biology research center in Vienna. His team integrates computational biologists, cell biologists, and clinicians to develop network cartography methods for disease module identification, with strong emphasis on virtual reality interfaces and multi-omics validation.

Fatih Albayrakمشاهده پروفایل

استادیار

• Rheumatology
• Internal Medicine
• Autoimmune Diseases
• +۵ مورد دیگر

Fatih Albayrak is an Assistant Professor at Gaziantep University Faculty of Medicine, Department of Internal Medicine, specializing in Rheumatology. He earned his medical degree from Marmara University Faculty of Medicine (English Program) between 2000-2007, completed his Internal Medicine specialization at Fırat University Faculty of Medicine (2010-2014), and further specialized in Rheumatology at Kahramanmaraş Sütçü İmam University (2018-2021). His research primarily focuses on Rheumatology within Internal Medicine, with particular expertise in inflammatory arthritis, autoimmune diseases, and connective tissue disorders. Dr. Albayrak's work examines the clinical manifestations, diagnostic challenges, and treatment approaches for conditions including rheumatoid arthritis, spondyloarthritis, Behçet's disease, systemic sclerosis, and osteomalacia. Analysis of his recent publications reveals a strong emphasis on biologic therapies and their safety profiles, particularly regarding secukinumab use in patients with malignancy history and inflammatory bowel disease risk. He also investigates ocular manifestations in rheumatoid arthritis, paraneoplastic arthritis, and the relationship between body mass index and disease markers in systemic sclerosis. Active researcher with 22 peer-reviewed articles in international journals Author of 11 book chapters on rheumatological topics Presented 50 conference papers at national and international meetings Board Member of Academic Rheumatology Association (since 2023) Member of Turkish Rheumatology Research and Education Association (since 2021) Dr. Albayrak has participated in numerous educational activities including ultrasound courses, capillaroscopy training, and various rheumatology symposia. His clinical work bridges internal medicine and rheumatology, with a particular focus on complex diagnostic cases and the intersection of rheumatic diseases with other medical specialties including oncology, ophthalmology, and gastroenterology.

• Pediatric Inflammatory Bowel Disease (IBD)
• Primary Immunodeficiencies (PIDs)
• Systems Biology
• +۳ مورد دیگر

Dr. Daniel Kotlarz is a Joint Helmholtz Young Investigator Group Leader at Helmholtz Munich, focusing on pediatric inflammatory bowel disease (IBD) and primary immunodeficiencies through a systems biology and multi-omics approach. Current Affiliation: Helmholtz Munich, Computational Health Center Previous Roles: Group Leader at Helmholtz Munich (2017–), Postdoctoral Fellow at Boston Children’s Hospital (2016–2014), Resident Physician at LMU Munich (2014–) His research explores the genetic and immune mechanisms underlying pediatric IBD, including roles in NOD2 polymorphisms , NOX1 deficiency , and TGF-beta signaling . His work integrates cell death regulation , reactive oxygen species (ROS) , and inflammatory pathways . Recent publications highlight discoveries in RIPK1 deficiency , TGFB1 mutations , and IL-21 receptor defects , linking these to immunodeficiency and chronic inflammation. These studies emphasize translational genomics and therapeutic targeting of key signaling nodes. Scientific Awards: Heinz Maier-Leibnitz Prize (2020) John Harries Prize (2019) Best Paper Prize (2019) Rolf Becker-Preis (2018) Rising Star scientist (2018) Innovation Prize (2015) Dr. Holger Müller Prize (2014)

• Cutaneous Immunology
• Autoimmune Diseases
• Systemic Lupus Erythematosus
• +۳ مورد دیگر

Dr. Allison C. Billi, MD, PhD, is an Assistant Professor in the Department of Dermatology at the University of Michigan, specializing in cutaneous immunology and autoimmune diseases. Her research focuses on the biological mechanisms behind female sex bias in autoimmune conditions like systemic lupus erythematosus (SLE). She identified VGLL3 as a key regulator driving lupus-like inflammation in female skin, demonstrating its role in systemic autoimmunity. Dr. Billi co-authored over 50 publications in journals including Nature , Science , and JCI Insight . Her research interests include: Transcriptional regulation of sex-biased autoimmunity Role of VGLL3 in lupus pathogenesis Skin-driven systemic inflammation Novel therapeutic targets for autoimmune disorders She received significant recognition including: Dermatology Foundation Research Fellowship (2019) AAD Young Investigator Award (2021) NIH K08 grant for VGLL3 research (2021-2026) Dr. Billi teaches medical students and residents, serves on departmental committees (Residency Task Force, Faculty Recruitment), and provides patient care in Medical Dermatology at Michigan Medicine.

Papaloukas Konstantinosمشاهده پروفایل

استاد

• Bioinformatics
• Computational Biology
• Biomedical Signal Processing
• +۷ مورد دیگر

Professor Papaloukas Konstantinos is affiliated with the University of Ioannina, where he leads research in bioinformatics and computational biology. His work focuses on integrating machine learning with biomedical data to address challenges in healthcare, such as disease prediction, biomarker discovery, and personalized medicine. He teaches courses including Bioinformatics and Introduction to Computer Science, and directs the Bioinformatics Laboratory. Research interests span computational analysis of proteins, automated tissue classification, and biomedical signal processing. Key areas of exploration include cardiovascular disease mechanisms, diabetes management, autoinflammatory disorders, and cancer biomarkers. His most recent studies leverage ensemble learning for hypoglycemia prediction and deep learning for autoinflammatory biomarker discovery. Publications highlight contributions to multimodal patient data integration, synthetic data generation for chronic diseases, and multimodal glucose prediction systems. Collaborative projects span cardiology, oncology, and infectious disease research. Despite no explicitly listed awards, his work demonstrates significant impact in computational medicine and bioinformatics. As part of his academic role, he advises students in bioinformatics and computational biology, though specific advisee names are not documented in available materials. His laboratory focuses on translating genomic and clinical data into actionable insights for clinical decision support.

J. Michelle Kahlenbergمشاهده پروفایل

دانشیار

• Autoimmune Diseases
• Rheumatology
• Cutaneous Lupus
• +۵ مورد دیگر

J. Michelle Kahlenberg is a physician-scientist and Associate Professor of Internal Medicine at the University of Michigan School of Medicine . She holds dual appointments in Dermatology and Rheumatology and serves as Vice Chair of Basic and Translational Research in the Department of Internal Medicine. Her clinical focus includes complex lupus management, particularly refractory cutaneous manifestations. Research Interests: Her work bridges innate immunity, interferon biology, and epithelial dysfunction in autoimmune diseases. Key areas are cutaneous lupus pathogenesis, photosensitivity drivers, and skin-systemic disease connections. She employs single-cell multi-omics and murine models to identify therapeutic targets like the IL-36/IFNK axis, inflammasome regulation, and mitochondrial Z-DNA sensing. Interferon Signaling Photosensitivity Mechanisms Keratinocyte Immunology Single-Cell Profiling Translational Autoimmunity Recent Publications emphasize cutaneous immunology, fibrosis, and epithelial-immune crosstalk across lupus, psoriasis, and scleroderma. Articles highlight therapeutic advances (e.g., TYK2 inhibitors) and novel pathogenic networks (e.g., cDC2A-CXCL13+ CD8+ T cell communication). Scientific Awards: 2018 PECASE (Presidential Early Career Award for Scientists and Engineers) 2022 American College of Rheumatology Henry Kunkel Young Investigator Awardee 2023 Henry Kunkel Society admission Inaugural Giles Boles and Dorothy Mulkey Research Chair in Rheumatology Training: She mentors students in the Immunology Training Program since 2013 and accepts new advisees. Her lab focuses on trainee development in translational immunology and dermatology research.

• Immunology
• Virology
• Aging
• +۸ مورد دیگر

Ruth R. Montgomery is a Professor of Medicine and Epidemiology at Yale School of Medicine and Yale School of Public Health , with a secondary appointment in Pathology . As Associate Dean for Scientific Affairs , she leads institutional research initiatives. Director, Yale CyTOF Facility (since 2013) Co-Chair, University Provost’s ITS Advisory Committee Principal Investigator, IMPACC Study on hospitalized COVID-19 patients Research Focus: Cellular immunology with emphasis on age-related immune dysregulation , innate immunity , and human translational studies of viral infections (West Nile, Dengue, Zika, SARS-CoV-2). Key methodologies include single-cell mass cytometry and multi-omics profiling . Scientific Contributions: 2025 AAAS Fellow; pioneer in aging-immunity interactions; identified CD16 polymorphisms reducing severe COVID-19 risk; discovered ELF4 deficiency as a monogenic mimic of Behçet's syndrome. Article Trends: Recent work spans age-dependent immune signatures in viral pathogenesis, multi-omics modeling of severe infections, and therapeutic immune monitoring in mepolizumab-treated populations. Collaborations span Yale Center for Research on Aging , Human and Translational Immunology Program , and Yale-BI Biomedical Data Science Fellowship . Honors: Fellow, American Association for the Advancement of Science (2025) Member, Connecticut Academy of Science and Engineering (2020) Key Collaborations: Frequent co-authorships with Erol Fikrig , Albert C. Shaw , Steven Kleinstein , and David Hafler across 161 publications. Faculty leadership roles in Chronic Disease Epidemiology and Public Health Data Science initiatives.

Puja Kumariمشاهده پروفایل

استادیار

• Innate Immunity
• Inflammasomes
• Host-Pathogen Interactions
• +۳ مورد دیگر

Puja Kumari is an Assistant Professor in the Department of Biological Sciences at Binghamton University. Her research focuses on innate immune mechanisms against bacterial pathogens and host-pathogen interactions, particularly involving inflammasomes, caspases, and cytokine signaling. She investigates how pathogens evade immunity while exploring therapeutic strategies for infectious diseases. Education: Postdoctoral training at the University of Connecticut Health School of Medicine (Farmington, CT, USA); PhD from Indian Institute of Science Education and Research (IISER) Bhopal (India); MSc from Madurai Kamaraj University (India); BSc from Ranchi University (India). Research Interests: Innate immunity in infectious/inflammatory diseases, inflammasome signaling pathways, host-pathogen interactions, cytokine-mediated immune responses, and mechanisms of pyroptosis. Her lab studies molecular and cellular basis of pathogen detection, immune evasion strategies, and inflammation-driven disease outcomes like septic shock. Research Trends: Recent articles focus on inflammasome regulation via extracellular vesicles, bacterial toxin interference with immune signaling, and cell-type specific roles of caspase-11 in sepsis. Work highlights both host defense mechanisms and pathological inflammation caused by excessive immune activation. Awards: No specific honors listed. Grants and Advising: No detailed information provided in text. Lab/Teams: Directs research group exploring immune sensing mechanisms with potential applications in vaccine development and antimicrobial therapies.

• Redox Biology
• Biochemistry
• Oxidative Stress
• +۵ مورد دیگر

Leslie B. Poole serves as Professor in the Department of Biochemistry at Wake Forest School of Medicine, Wake Forest University, where she has been faculty since 1992. She holds leadership roles as Director of the Center for Structural Biology and Co-Director of the Center for Redox Biology & Medicine, contributing significantly to institutional research infrastructure and scientific community engagement. Her educational background includes: B.A. in Biology & Chemistry, Wake Forest University (1980) Ph.D. in Biochemistry, Wake Forest University (1988) Postdoctoral Fellowship, University of Maryland-College Park (1988-1991) Dr. Poole is an internationally recognized expert in redox biology , specializing in oxidation/reduction control of protein and enzyme function. Her pioneering work defined the chemistry of biological thiol redox reactions and established hydrogen peroxide as a critical signaling molecule. Her research bridges biochemistry , cancer biology , and translational medicine , with applications in developing novel therapeutics and diagnostic tools for oxidative stress-related diseases. Current investigations focus on redox regulation in cancer progression, cardiotoxicity of chemotherapeutics, and mitochondrial oxidative stress mechanisms. Analysis of her recent publications (2022-2025) reveals persistent emphasis on peroxiredoxin function, protein sulfenylation detection, and redox-mediated signaling in cancer and inflammation. Key trends include therapeutic targeting of redox vulnerabilities in KRAS-mutant cancers, mitochondrial redox control of immune responses, and innovative approaches to mitigate chemotherapy-induced cardiotoxicity through redox modulation. Her scientific recognition includes: 2024 WFU Friends of Chemistry Distinguished Alumni Award Dr. Poole has secured over $16 million in extramural funding (94% from NIH), demonstrating exceptional grant-writing success. She has mentored numerous graduate students and postdoctoral fellows while leading collaborative research initiatives. Her administrative contributions span university committees including safety oversight and Women in Medicine & Science advocacy. She directs the Center for Structural Biology and co-directs the Center for Redox Biology & Medicine, where her team develops redox-based detection technologies including the patented platform commercialized through Xoder Tech, LLC, a Women Owned Small Business she co-founded.

Donald P. Goldsmithمشاهده پروفایل

استاد

• Pediatric Rheumatology
• Autoinflammatory Diseases
• Juvenile Arthritis
• +۳ مورد دیگر

Donald P. Goldsmith, MD, is a Professor of Pediatrics at Drexel University College of Medicine and Chief of the Section of Rheumatology at St. Christopher's Hospital for Children in Philadelphia. His career spans over three decades, focusing on pediatric rheumatology and immunology. Board certified in pediatrics, rheumatology, and allergy/immunology Developed the Childhood Health Assessment Questionnaire (CHAQ), a globally utilized tool for juvenile idiopathic arthritis Described NOMID (now recognized as a primary autoinflammatory disorder) His research interests include autoinflammatory diseases, therapeutic agents for juvenile arthritis, and neurological complications of rheumatic disorders. Recent work emphasizes hyper IgD periodic fever syndrome (HIDS) and PFAPA syndrome. Dr. Goldsmith has received numerous accolades, including: Master of the American College of Rheumatology (2012) Distinguished Academic Achievement Award, University of Vermont College of Medicine (2017) Joseph Lee Hollander Award (2006) Multiple 'Top Doctor' recognitions by Philadelphia magazine He has served as a role model for pediatric residents, organized the PEDS consortium for academic collaboration, and contributed extensively to the Journal of Clinical Rheumatology as a pediatric editor.

• Virology
• Immunology
• Bacteriology
• +۶ مورد دیگر

Prof. Dr. Pelin YÜKSEL MAYDA is a Professor of Medical Microbiology at Kocaeli Health and Technology University, currently serving as Vice Rector. She has held leadership roles including Dean of the Faculty of Pharmacy and Health Sciences, and Head of the Department of Medical Microbiology. Her academic journey includes degrees from İstanbul University and Trakya University, with postgraduate training in Medical Microbiology and a research stint at Johns Hopkins University. Education: BSc (1995, İstanbul University), MSc (1999, İstanbul University), PhD (2005, Trakya University). Roles: Professor since 2021, Associate Professor since 2015, Department Head (2018–present), and Administrative Leadership (e.g., Vice Rector, 2022–present). Her research focuses on virology, immunology, bacteriology, parasitology, and mycology, with over 50 international publications. Key topics include antimicrobial resistance, vaccine efficacy, and molecular diagnostics. She has received the BRONZ MADALYA-İNOVASYON (2024) for innovation in health technologies. Teaching: Courses in Microbiology across Medicine, Dentistry, Pharmacy, and Health Sciences. Supervised numerous graduate theses and leads projects on antimicrobial agents and dental materials. Administrative Contributions: Ethics Committee Chair, Scientific Research Unit Head, and curriculum development roles. Active in international conferences (e.g., KOCAELİ Health Tech Conference 2024, Kapadokya Science Congress 2023).

Sergio Catzمشاهده پروفایل

استاد

• Intracellular Vesicular Transport
• Immunology
• Molecular Biology
• +۷ مورد دیگر

Sergio Catz, PhD is a Professor in the Department of Molecular and Cellular Biology at Scripps Research. His research focuses on intracellular vesicular transport mechanisms and their roles in immunity, inflammation, and disease. He leads a laboratory utilizing super-resolution microscopy and systems biology approaches to study Rab GTPases and vesicular trafficking in innate immune cells. Education: PhD in Biological Sciences, University of Buenos Aires (1997) BSc in Biochemistry, University of Buenos Aires (1991) Research Interests: His work investigates molecular mechanisms of autophagy, exocytosis, and phagocytosis, with applications to coronary artery disease, lysosomal storage disorders, and autoinflammatory syndromes. The lab develops small-molecule inhibitors/activators of vesicular trafficking and employs high-throughput screening assays. Awards & Leadership: Chair-elect, Neutrophil Biennial International Symposium (2026) NIH Study Section Member (CSF1, MBPP) Editorial Board, Journal of Leukocyte Biology Recipient: Prize Boeringher Ingelheim (1995) Lab & Collaborations: The lab is internationally recognized for studying vesicular trafficking in innate immunity. Current projects include pre-clinical trials for lysosomal disorders and viral encephalitis using novel compounds.

• Internal Medicine
• Lipidology
• Cardiovascular Risk Prevention
• +۱۴ مورد دیگر

Cristina Soler Ferrer is an Associate Professor in the Department of Medical Sciences at the University of Girona and an Assistant Physician Specialist in Internal Medicine at Santa Caterina Hospital, Salt, Girona, Spain. She leads the Lipid Unit and the International Health and Tropical Medicine Unit at the hospital, contributing significantly to clinical care, research, and academic training. Degree in Medicine and Surgery, Autonomous University of Barcelona (1990) Specialist in Internal Medicine, Vall d'Hebron Hospital (1996) Level C Certification in Catalan Her research focuses on lipid disorders, cardiovascular risk prevention, tropical medicine, and infectious diseases. She has published extensively on dyslipidemia, familial hypercholesterolemia, Chagas disease, malaria, strongyloidiasis, and the metabolic and environmental determinants of diseases like COVID-19. Her work often involves multicenter collaborations, particularly through the Network of Lipid and Arteriosclerosis Units (XULA) and the Spanish Society of Tropical Medicine and International Health (SEMTSI). Recent publications highlight her interest in the role of lipids in viral infections, air pollution and disease severity, polygenic risk in hypercholesterolemia, and clinical guidelines for lipid management. She has contributed to national and regional consensus documents on dyslipidemia and cardiovascular prevention. President, Network of Lipid and Arteriosclerosis Units (XULA), 2021–2023 Secretary, XULA, 2023–present Vice President, Girona Medical Association, 2010–2014 Member, Spanish Society of Arteriosclerosis (SEA) Member, SEMTSI Working Group on Chagas Disease Member, Catalan Department of Health Chagas Working Group Dr. Soler Ferrer has been involved in numerous research projects and collaborative networks, including the STACOV-XULA group studying COVID-19, and has co-authored over 20 peer-reviewed publications in the last decade. She mentors within research teams and contributes to postgraduate medical education through guideline development and academic teaching. Her work bridges clinical practice, public health, and translational research, particularly in underserved areas like tropical medicine and rare lipid disorders.

• Cancer
• Cancer Immunology
• Caspases
• +۵ مورد دیگر

Dr. Emma Creagh is an Associate Professor in the Department of Biochemistry within the School of Biochemistry and Immunology at Trinity College Dublin. Her research focuses on the intersection of inflammation, immunology, and cancer, particularly examining the role of inflammatory caspases in disease progression across multiple organ systems. Dr. Creagh's research interests span several critical areas of biomedical science: Cancer and Cancer Immunology, with particular focus on gastrointestinal cancers The role of caspases in inflammation and immune responses Inflammasome-mediated inflammation pathways The connection between chronic inflammation and cancer development Esophageal and colorectal cancer mechanisms TLR signaling in disease progression Analysis of Dr. Creagh's recent publications reveals a cohesive research program centered on inflammatory caspases (particularly -1, -4, -5, and -11) and their diverse roles in disease. Her work spans gastrointestinal cancers (particularly esophageal and colorectal), inflammatory bowel disease, allergic airway inflammation, and psoriasis, demonstrating how these enzymes regulate immune responses across multiple pathological contexts. A significant portion of her research investigates the molecular mechanisms linking inflammation to cancer development, with implications for novel therapeutic targets. Dr. Creagh has received numerous scientific awards and recognitions: Wellcome Trust Career Development Fellowship (2006-2011) Broad Medical Research Program Fellowship (2010-2012) TCD Pathfinder Award (2015) Winner of Oral presentation at Irish Society of Gastroenterology Meeting (2016) Voted 'Favorite Woman in Science' by TCD General Science Students (2017-2019) Senior Council Member of the Irish Association for Cancer Research (IACR) since 2020 Dr. Creagh maintains active collaborations with clinicians at St. Vincent's Hospital and participates in numerous national and international research networks. Her laboratory serves as a training ground for the next generation of immunologists and cancer researchers, with several students presenting their work at major conferences. She regularly presents her findings at specialized immunology meetings and gastroenterology conferences, contributing to the advancement of knowledge in inflammation-related diseases.